Govt Mulls Norms For QR Code On Cosmetics, Apparel Brands To Curb Counterfeits

New Delhi: India is looking to lay down norms to counter the menace of counterfeit products mimicking the names and labels of brands of garments, apparel and cosmetics. The representatives from garments, apparel and cosmetics’ industries stated that they’re ready to share available data on counterfeit products to aid better policymaking by the government, sources told CNBC-TV18.

These entities met with Consumer Affairs Secretary Rohit Kumar Singh and discussed checking the sale of fake or counterfeit brands of apparel and cosmetics. The government is mulling guidelines to install QR codes on branded apparel and cosmetics to ease identification by users, as per sources. The proposed guidelines also aim to cover cosmetics sold via social media posts or reels.
Sources indicated that the government is mulling guidelines to install QR codes on branded apparel and cosmetics to ease identification by users. The proposed guidelines also aim to cover cosmetics sold via social media posts or reels.
A joint report issued by Credit Rating Information Services of India Limited (CRISIL) and the Authentication Solution Providers Association (ASPA) in January 2024 pointed out that 25% to 30% of all products sold in India were spurious. The report termed counterfeiting the most prevalent in the apparel and fast-moving consumer goods (FMCG) sectors.
The report claims 31% counterfeit products among apparel, followed by 28% in the FMCG segment, 25% in automotives, 20% in pharmaceuticals, 17% in consumer durables and 16% in agrochemicals.
The report covered 12 Indian cities: Jalandhar, Delhi, Agra, Jaipur, Patna, Indore, Ahmedabad, Kolkata, Mumbai, Hyderabad, Bangalore and Chennai. It also contended that 31% of consumers willingly bought spurious products, while 27% of consumers were unaware of having bought counterfeit products.

Related Posts

Indian Pharma Majors Plan to Invest in US

National Harbor (US): Top Indian pharmaceutical companies, including at least three from Hyderabad, are all set to announce major investments to set up new facilities in the United States during…

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Emcure Pharmaceuticals Ltd on Tuesday reported a 24 per cent increase in consolidated net profit at ₹243.74 crore in the fourth quarter ended March 2026 on the back of robust…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Indian Pharma Majors Plan to Invest in US

Indian Pharma Majors Plan to Invest in US

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification